Morgan Stanley Icu Medical Inc Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Icu Medical Inc stock. As of the latest transaction made, Morgan Stanley holds 538,427 shares of ICUI stock, worth $59.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

538,427

Previous 576,960 6.68%

Holding current value

$59.4 Million

Previous $80.1 Million 11.19%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	SELL	$127.74 - $151.04 $4.92 Million - $5.82 Million	-38,533 Reduced 6.68%	538,427 $71.2 Million
Q1 2025 May 15, 2025	SELL	$130.05 - $172.3 $5.63 Million - $7.46 Million	-43,271 Reduced 6.98%	576,960 $80.1 Million
Q4 2024 Feb 14, 2025	BUY	$153.2 - $183.79 $1.2 Million - $1.44 Million	7,813 Added 1.28%	620,231 $96.2 Million
Q3 2024 May 14, 2025	BUY	$114.88 - $182.17 $4.82 Million - $7.64 Million	41,937 Added 7.35%	612,418 $112 Million
Q3 2024 Nov 14, 2024	BUY	$114.88 - $182.17 $4.82 Million - $7.64 Million	41,937 Added 7.35%	612,418 $112 Million
Q2 2024 May 14, 2025	SELL	$94.53 - $120.55 $4.7 Million - $6 Million	-49,750 Reduced 8.02%	570,481 $67.7 Million
Q2 2024 Oct 17, 2024	SELL	$94.53 - $120.55 $7.59 Million - $9.67 Million	-80,240 Reduced 12.33%	570,481 $67.7 Million
Q2 2024 Aug 14, 2024	SELL	$94.53 - $120.55 $7.59 Million - $9.67 Million	-80,240 Reduced 12.33%	570,481 $67.7 Million
Q1 2024 Oct 17, 2024	BUY	$86.88 - $112.48 $6.97 Million - $9.03 Million	80,240 Added 14.07%	650,721 $69.8 Million
Q1 2024 Aug 16, 2024	BUY	$86.88 - $112.48 $5.74 Million - $7.43 Million	66,088 Added 11.3%	650,721 $69.8 Million
Q1 2024 May 15, 2024	BUY	$86.88 - $112.48 $5.74 Million - $7.43 Million	66,088 Added 11.3%	650,721 $69.8 Million
Q4 2023 Aug 16, 2024	BUY	$81.08 - $119.29 $1.15 Million - $1.69 Million	14,152 Added 2.48%	584,633 $58.3 Million
Q4 2023 Feb 13, 2024	SELL	$81.08 - $119.29 $5.45 Million - $8.02 Million	-67,193 Reduced 10.31%	584,633 $58.3 Million
Q3 2023 Nov 15, 2023	BUY	$115.27 - $182.23 $3.33 Million - $5.27 Million	28,896 Added 4.64%	651,826 $77.6 Million
Q2 2023 Aug 14, 2023	SELL	$161.03 - $209.15 $11 Million - $14.2 Million	-68,061 Reduced 9.85%	622,930 $111 Million
Q1 2023 May 15, 2023	BUY	$153.15 - $198.21 $1.7 Million - $2.2 Million	11,079 Added 1.63%	690,991 $114 Million
Q4 2022 Feb 14, 2023	BUY	$136.25 - $165.56 $64.9 Million - $78.8 Million	476,012 Added 233.45%	679,912 $107 Million
Q3 2022 Nov 14, 2022	BUY	$149.44 - $188.1 $13.6 Million - $17.2 Million	91,244 Added 80.99%	203,900 $30.7 Million
Q2 2022 Oct 27, 2022	BUY	$161.4 - $229.7 $13.4 Million - $19.1 Million	83,230 Added 282.85%	112,656 $18.5 Million
Q2 2022 Aug 15, 2022	BUY	$161.4 - $229.7 $13.4 Million - $19.1 Million	83,230 Added 282.85%	112,656 $18.5 Million
Q1 2022 Oct 27, 2022	SELL	$203.51 - $247.46 $16.9 Million - $20.6 Million	-83,230 Reduced 73.88%	29,426 $6.55 Million
Q1 2022 May 13, 2022	BUY	$203.51 - $247.46 $1.09 Million - $1.33 Million	5,375 Added 22.35%	29,426 $6.55 Million
Q4 2021 Feb 14, 2022	SELL	$220.96 - $247.44 $1.23 Million - $1.38 Million	-5,561 Reduced 18.78%	24,051 $5.71 Million
Q3 2021 Nov 15, 2021	BUY	$186.8 - $260.0 $5.53 Million - $7.7 Million	29,612 New	29,612 $6.91 Million

Others Institutions Holding ICUI

# of Institutions

302

Shares Held

25M

Call Options Held

32.5K

Put Options Held

2.1K

View Full List

About ICU MEDICAL INC

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $2.64B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

More about ICUI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account